Abstract:Among the current five Variants of Concern, infections caused by SARS-CoV-2 B.1.617.2 (Delta) variant are often associated with the greatest severity. Despite recent advances on the molecular basis of elevated pathogenicity using recombinant proteins, the architecture of intact Delta virions remains veiled. Moreover, pieces of molecular evidence for the detailed mechanism of S-mediated membrane fusion are missing. Here, we showed the pleomorphic nature of Delta virions from electron beam inactivated samples and reported the in situ structure and distribution of S on the authentic Delta variant. We also captured the virus-virus fusion events, which provided pieces of structural evidence for Delta's attenuated dependency on cellular factors for fusion activation, and proposed a model of S-mediated membrane fusion. Besides, site-specific glycan analysis revealed increased oligomannose-type glycosylation of native Delta S than that of the WT S. Together, these results disclose distinctive factors of Delta being the most virulent SARS-CoV-2 variant.SignificanceDelta remains as the most virulent SARS-CoV-2 variant. Its significantly enhanced fusogenicity may account for the severe symptoms. However, in situ structural characterization of Delta is missing. Here, we studied the morphology of Delta virions from both paraformaldehyde (PFA) and electron beam inactivated samples and determined the high-resolution structure, distribution, and glycan compositions of S in situ. The results were compared to those of previously characterized recombinant Delta and native WT S, revealing distinctive features for the elevated pathogenicity of Delta variant. We further captured snapshots of ongoing Delta virus-virus fusion, from which intermediate steps of S-mediated membrane fusion were interpreted.

Toward an atomistic model of SARS-CoV-2

Toward Atomistic Models of Intact Severe Acute Respiratory Syndrome Coronavirus 2 Via Martini Coarse-Grained Molecular Dynamics Simulations

Cryo-electron Microscopy Structures of the SARS-CoV Spike Glycoprotein Reveal a Prerequisite Conformational State for Receptor Binding

Biophysical Modeling of SARS-CoV-2 Assembly: Genome Condensation and Budding

Molecular Architecture of the SARS-CoV-2 Virus

Development of Multiscale Ultra-Coarse-Grained Models for the SARS-CoV-2 Virion from Cryo-Electron Microscopy Data

In situ architecture and membrane fusion of SARS-CoV-2 Delta variant

Graph, pseudoknot, and SARS-CoV-2 genomic RNA: A biophysical synthesis

Cryo-electron microscopy structure of the SADS-CoV spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins

Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells

Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus

SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography

Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane

CryoEM and AI Reveal a Structure of SARS-CoV-2 Nsp2, a Multifunctional Protein Involved in Key Host Processes.

In Vivostructural Characterization of the Whole SARS-CoV-2 RNA Genome Identifies Host Cell Target Proteins Vulnerable to Re-Purposed Drugs

Computational Simulations Reveal the Binding Dynamics Between Human ACE2 and the Receptor Binding Domain of SARS-CoV-2 Spike Protein

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2

Structural Insights into Sars Coronavirus Proteins

Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeutics

Structural proteomics of the SARS coronavirus: a model response to emerging infectious diseases